JPH1192378A - Hair tonic liquid for external use - Google Patents
Hair tonic liquid for external useInfo
- Publication number
- JPH1192378A JPH1192378A JP9253999A JP25399997A JPH1192378A JP H1192378 A JPH1192378 A JP H1192378A JP 9253999 A JP9253999 A JP 9253999A JP 25399997 A JP25399997 A JP 25399997A JP H1192378 A JPH1192378 A JP H1192378A
- Authority
- JP
- Japan
- Prior art keywords
- minoxidil
- hair
- surface tension
- viscosity
- boiling point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 7
- 230000001256 tonic effect Effects 0.000 title abstract 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229960003632 minoxidil Drugs 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 238000009835 boiling Methods 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 239000002798 polar solvent Substances 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 4
- 230000003779 hair growth Effects 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- -1 sorbitan fatty acid ester Chemical class 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 210000004761 scalp Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241000282553 Macaca Species 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Chemical class 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical class CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Chemical class 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229960003517 isothipendyl Drugs 0.000 description 1
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical compound C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229950004864 olamine Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- TXGSOSAONMOPDL-UHFFFAOYSA-N propan-2-yl 3,4,5-trihydroxybenzoate Chemical compound CC(C)OC(=O)C1=CC(O)=C(O)C(O)=C1 TXGSOSAONMOPDL-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ミノキシジルを含
有した外用育毛液剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair growth solution for external use containing minoxidil.
【0002】[0002]
【従来の技術】従来、外用薬剤を塗布するのは、指によ
る直接塗布や、脱脂綿、刷毛などの器具を利用して塗布
する方法が一般的である。そのような方法は、皮膚に塗
布した後、吸収されて血中に移行する薬剤については簡
易であるため好ましい投与形態である。2. Description of the Related Art Conventionally, an external medicine is generally applied by direct application with a finger or by using a device such as absorbent cotton or a brush. Such a method is a preferable administration form because it is simple for a drug that is absorbed and transferred into the blood after application to the skin.
【0003】しかし、塗布部分に滞留して薬効を発現す
る薬剤については、確実な薬効発現のためには、一定面
積の皮膚に対しては一定量の薬剤塗布が必要である。と
ころが、従来の方法では、塗布部位の皮膚の状態や製剤
の性質により、投与部位からの製剤の垂れや過剰な広が
りが生じたり、逆に塗布部にはじかれてしまい十分に患
部へ薬剤を投与することができないなど、投与量に見合
うだけの効果が得られないことがあった。However, with respect to a drug which stays in an applied portion and exhibits a medicinal effect, it is necessary to apply a certain amount of the medicament to a certain area of skin in order to surely exhibit the medicinal effect. However, in the conventional method, depending on the condition of the skin at the application site and the properties of the preparation, the preparation drips or excessively spreads from the administration site, or on the contrary, it is repelled by the application section and the drug is sufficiently administered to the affected area In some cases, it was not possible to obtain an effect commensurate with the dose.
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、近年育
毛剤として着目されているミノキシジルの育毛効果につ
いて検討したところ、外用育毛剤としてミノキシジルを
投与する場合は、ミノキシジルを塗布部位の真皮に滞留
させた方が、その育毛効果が高いことを見出した。その
ため、確実な育毛効果の発現にはミノキシジルを均一に
塗布することが必要になるが、従来、ミノキシジルを均
一に塗布する方法は知られていない。The present inventors have studied the hair-growth effect of minoxidil, which has recently attracted attention as a hair-growth agent. When administering minoxidil as an external hair-growth agent, the present inventors applied minoxidil to the dermis of the application site. It was found that the hair retention effect was higher when the hair was retained. For this reason, it is necessary to apply minoxidil evenly in order to surely achieve the hair growth effect. However, a method of applying minoxidil uniformly has not been known.
【0005】本発明の目的は、塗布部位以外への薬剤の
広がりやたれが無く、ミノキシジルを均一に塗布し、か
つ、皮膚表面へのミノキシジルの浸透を可能にした育毛
剤を提供することにある。[0005] An object of the present invention is to provide a hair restorer which does not spread or dripping of a drug to a site other than the application site, and which can uniformly apply minoxidil and which allows permeation of minoxidil to the skin surface. .
【0006】[0006]
【課題を解決するための手段】本発明者らは研究の結
果、ミノキシジルを配合した液剤の粘度および表面張力
を特定の範囲に設定すると、塗布した際に製剤が塗布部
位以外へ広がらず、かつ、ミノキシジルを均一に塗布で
きることを見出し本発明を完成した。Means for Solving the Problems As a result of research, the present inventors have set the viscosity and surface tension of a liquid formulation containing minoxidil in a specific range, and when applied, the formulation does not spread beyond the application site, and And found that minoxidil can be applied uniformly, and completed the present invention.
【0007】すなわち本発明は、製剤全体の0.1〜5
重量%のミノキシジルを配合し、25℃での粘度が1.
5〜15mPa・sであり、かつ、25℃での表面張力が2
5〜30dyne/cmであることを特徴とする外用育毛液剤
である。That is, the present invention relates to the preparation of 0.1 to 5
1% by weight of minoxidil and a viscosity at 25 ° C. of 1.
5 to 15 mPa · s and a surface tension at 25 ° C. of 2
It is a hair growth solution for external use characterized by being 5 to 30 dyne / cm.
【0008】[0008]
【発明の実施の形態】本発明の外用育毛剤は、25℃で
の粘度を1.5〜15mPa・s、好ましくは2〜6mPa・sに
調整する必要がある。粘度が1.5mPa・s未満である
と、液剤を塗布した後の余分な広がりや垂れを防止する
ことができず、粘度が15mPa・sを越えると、円滑な展
延が妨げられ、ミノキシジルを均一に塗布することが困
難になるからである。本発明での粘度は振動式粘度計に
よって測定した値である。BEST MODE FOR CARRYING OUT THE INVENTION The external hair restorer of the present invention needs to adjust the viscosity at 25 ° C. to 1.5 to 15 mPa · s, preferably 2 to 6 mPa · s. If the viscosity is less than 1.5 mPas, it is not possible to prevent excessive spreading and dripping after applying the liquid agent, and if the viscosity exceeds 15 mPas, smooth spreading is hindered, and minoxidil This is because it becomes difficult to apply the coating uniformly. The viscosity in the present invention is a value measured by a vibrating viscometer.
【0009】本発明においては、液剤の粘度が不足する
ときは、エチルセルロース、カルボキシメチルセルロー
ス塩、カルボキシビニルポリマー、ヒドロキシプロピル
セルロース、ヒドロキシプロピルメチルセルロース、キ
サンタンガム、メチルセルロース、脂肪酸モノグリセリ
ド(ペンタデカン酸モノグリセリドなど)、多価アルコ
ール(グリセリン、プロピレングリコール、1,3−ブ
チレングリコールなど)、セタノールなどの増粘剤を配
合することにより粘度を調節することができる。In the present invention, when the viscosity of the solution is insufficient, ethyl cellulose, carboxymethylcellulose salt, carboxyvinyl polymer, hydroxypropylcellulose, hydroxypropylmethylcellulose, xanthan gum, methylcellulose, fatty acid monoglyceride (pentaglycan monoglyceride, etc.), polyvalent The viscosity can be adjusted by blending a thickener such as alcohol (glycerin, propylene glycol, 1,3-butylene glycol, etc.), cetanol and the like.
【0010】本発明の外用育毛剤は、25℃での表面張
力を25〜30dyne/cmの範囲になるように設定しなけ
ればならない。男性型脱毛症をきたしている、またはき
たしつつある頭皮には、通常よりも皮脂成分が多く、一
般的な頭皮の表面張力より低い値となることから、表面
張力が25dyne/cm未満であると、頭皮における汗(水
溶性)成分によって塗布むらができ、一方30dyne/cm
を越えてしまうと、頭皮における皮脂(脂溶性)成分に
よって塗布むらが生じるからである。本発明での表面張
力測定はウィルヘルミー法(Wilhelmy法)による測定値
である。[0010] The external hair growth agent of the present invention must be set so that the surface tension at 25 ° C is in the range of 25 to 30 dyne / cm. Scalp causing orrogenetic alopecia has more sebum components than usual in the scalp, which is lower than the surface tension of general scalp, so the surface tension is less than 25 dyne / cm , Uneven application due to sweat (water-soluble) component in scalp, while 30dyne / cm
This is because if the amount exceeds the range, uneven coating may occur due to sebum (fat-soluble) components in the scalp. The surface tension measurement in the present invention is a value measured by the Wilhelmy method.
【0011】表面張力は配合する成分などの複雑な要因
により変動するが、その調節は主に水とエタノールの配
合比により行い、水を多くすると表面張力が増加し、エ
タノールを多くすると表面張力は低下する。また、界面
活性剤(ソルビタン脂肪酸エステル、ポリグリセリン脂
肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エ
ステル、ポリオキシエチレンソルビット脂肪酸エステ
ル、ポリオキシエチレングリセリン脂肪酸エステル、ポ
リエチレングリコール脂肪酸エステル、ポリオキシエチ
レンアルキルエーテル、ポリオキシエチレンポリオキシ
プロピレンアルキルエーテル、ポリオキシエチレンアル
キルフェニルエーテル、ポリオキシエチレン硬化ヒマシ
油、ポリオキシエチレンヒマシ油、ポリオキシエチレン
ミツロウ誘導体、ポリオキシエチレンラノリン誘導体、
ポリオキシエチレンアルキルアミド、ポリオキシエチレ
ンアルキルアミン、レシチン誘導体、高分子乳化剤な
ど)などの表面張力低下剤などにより減少させることも
できる。Although the surface tension varies depending on complex factors such as components to be blended, the adjustment is mainly performed by the blending ratio of water and ethanol. The surface tension increases when the amount of water increases, and the surface tension increases when the amount of ethanol increases. descend. Also, surfactants (sorbitan fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbite fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene Polyoxypropylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene beeswax derivative, polyoxyethylene lanolin derivative,
Polyoxyethylene alkylamides, polyoxyethylene alkylamines, lecithin derivatives, polymer emulsifiers, etc.) can be used to reduce the surface tension.
【0012】本発明の外用育毛剤に配合するミノキシジ
ルは製剤全体の0.1〜5重量%の範囲である必要があ
る。0.1重量%未満であると、ミノキシジルの育毛効
果が弱くなり、5重量%を越えて配合すると、塗布むら
があっても育毛効果が発現するからである。The amount of minoxidil to be added to the topical hair restorer of the present invention must be in the range of 0.1 to 5% by weight of the whole preparation. If the amount is less than 0.1% by weight, the hair-growth effect of minoxidil will be weak, and if it is more than 5% by weight, the hair-growth effect will be exhibited even if the coating is uneven.
【0013】本発明の外用育毛剤は、基剤として沸点が
100℃以下の極性溶媒および沸点が150℃以上の有
機溶媒とを併用して配合すると、塗布したときのミノキ
シジルをより均一に塗布することができる。[0013] When the hair growth agent for external use of the present invention is used in combination with a polar solvent having a boiling point of 100 ° C or lower and an organic solvent having a boiling point of 150 ° C or higher as a base, minoxidil is more uniformly applied when applied. be able to.
【0014】沸点が150℃以上の有機溶媒とは、エチ
レングリコール、ジエチレングリコール、トリエチレン
グリコール、1,3−ブチレングリコール、ジプロピレ
ングリコール、グリセリン、プロピレングリコール、ポ
リエチレングリコールなどであり、育毛効果の点から好
ましいものとしてエチレングリコール、ジエチレングリ
コール、トリエチレングリコール、プロピレングリコー
ルおよびジプロピレングリコールがあげられる。これら
の沸点が150℃以上の有機溶媒の配合量は、製剤全体
の0.1〜25重量%が好ましい。The organic solvent having a boiling point of 150 ° C. or higher includes ethylene glycol, diethylene glycol, triethylene glycol, 1,3-butylene glycol, dipropylene glycol, glycerin, propylene glycol, polyethylene glycol and the like. Preferred are ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol and dipropylene glycol. The amount of the organic solvent having a boiling point of 150 ° C. or higher is preferably 0.1 to 25% by weight of the whole preparation.
【0015】沸点が100℃以下の極性溶媒とは、メタ
ノール、エタノール、変性エタノール、イソプロパノー
ルなどがあげられ、最も好ましいものとして、エタノー
ルおよびイソプロパノールがあげられる。また、これら
の極性溶媒の配合量は、製剤全体の50〜99.5重量
%が好ましい。The polar solvent having a boiling point of 100 ° C. or lower includes methanol, ethanol, denatured ethanol, isopropanol and the like, and most preferred are ethanol and isopropanol. The amount of these polar solvents is preferably 50 to 99.5% by weight of the whole preparation.
【0016】本発明の外用育毛剤は、必要に応じて、溶
解補助剤(各種植物油、各種動物油、アルキルグリセリ
ルエーテル、乳酸、リン酸、水酸化ナトリウムなど)、
炭化水素(流動パラフィン、スクワランなど)、抗酸化
剤(ジブチルヒドロキシトルエン、ピロ亜硫酸ナトリウ
ム、トコフェロール、エデト酸ナトリウム、アスコルビ
ン酸、イソプロピルガレートなど)、乳化安定剤、ゲル
化剤(高分子など)、粘着剤など、清涼化剤(メントー
ル、ハッカ油、カンフルなど)、ビタミン類(ビタミン
E、ビタミンAなど)、その他の成分としては通常育毛
剤に用いられる成分である血管拡張剤(塩化カルプロニ
ウム、ニコチン酸ベンジル、センブリ抽出液、オタネニ
ンジンエキス、ビタミンEアセテート、トウガラシチン
キなど)、抗ヒスタミン剤(塩酸ジフェンヒドラミン、
塩酸イソチペンジルなど)、抗炎症剤(グリチルレチン
酸、グアイアズレンなど)、角質溶解剤(尿素、サリチ
ル酸など)、殺菌剤(グルコン酸クロルヘキシジン、イ
ソプロピルメチルフェノール、第4級アンモニウム塩、
ヒノキチオール、ピロクトンオラミンなど)、保湿剤
(ヒアルロン酸ナトリウム、コンドロイチン硫酸な
ど)、各種動植物(イチイ、ボタンピ、カンゾウ、オト
ギリソウ、附子、ビワ、カワラヨモギ、コンフリー、ア
シタバ、サフラン、サンシシ、ローズマリー、セージ、
モッコウ、セイモッコウ、ホップ、プラセンタなど)の
抽出物、ビタミン類(酢酸レチノール、塩酸ピリドキシ
ン、アスコルビン酸、硝酸チアミン、シアノコバラミ
ン、ビオチンなど)香料、色素などの通常使用される成
分を配合できる。The externally used hair restorer of the present invention may contain, if necessary, a solubilizer (various vegetable oils, various animal oils, alkyl glyceryl ether, lactic acid, phosphoric acid, sodium hydroxide, etc.),
Hydrocarbons (liquid paraffin, squalane, etc.), antioxidants (dibutylhydroxytoluene, sodium pyrosulfite, tocopherol, sodium edetate, ascorbic acid, isopropyl gallate, etc.), emulsion stabilizers, gelling agents (polymers, etc.), adhesion Agents, such as fresheners (menthol, peppermint oil, camphor, etc.), vitamins (vitamin E, vitamin A, etc.), and other components commonly used in hair restorers such as vasodilators (carpronium chloride, nicotinic acid) Benzyl, Assembly extract, Panax ginseng extract, Vitamin E acetate, Pepper tincture, etc.), Antihistamines (Diphenhydramine hydrochloride,
Isothipendyl hydrochloride, etc.), anti-inflammatory agents (glycyrrhetinic acid, guaiazulene, etc.), keratolytic agents (urea, salicylic acid, etc.), fungicides (chlorhexidine gluconate, isopropylmethylphenol, quaternary ammonium salts,
Hinokitiol, pyrocton olamine, etc.), humectants (sodium hyaluronate, chondroitin sulfate, etc.), various animals and plants (yew, buttonpi, licorice, hypericum, sticky rice, loquat, valerium, comfrey, ashitaba, saffron, sanshishi, rosemary, Sage,
Commonly used ingredients such as extracts of mocktail, seaweed, hops, placenta, etc., vitamins (retinol acetate, pyridoxine hydrochloride, ascorbic acid, thiamine nitrate, cyanocobalamin, biotin, etc.) flavors and pigments can be blended.
【0017】本発明の育毛剤は液剤、乳剤などの製剤を
通常の方法によって製造することができる。The hair restorer of the present invention can be prepared in the form of a solution, emulsion or the like by a usual method.
【0018】[0018]
【実施例】以下、実施例および試験例により本発明をさ
らに詳細に説明する。なお、粘度の測定は振動式粘度計
(VM−100A:山一電気製)、表面張力はCBVP
式表面張力計(協和CBVP式表面張力計A1/A3
型:協和科学製)により測定した。The present invention will be described in more detail with reference to the following Examples and Test Examples. The viscosity was measured by a vibrating viscometer (VM-100A: manufactured by Yamaichi Denki), and the surface tension was measured by CBVP.
Type surface tensiometer (Kyowa CBVP type surface tensiometer A1 / A3
(Type: manufactured by Kyowa Kagaku).
【0019】実施例 表1に示した処方で、1g ミノキシジル、各種溶媒およ
び増粘剤としてメチルセルロースを加え、精製水で全量
を100mlとして撹拌溶解し、ローション剤を調製し
た。Example 1 g of minoxidil, various solvents and methylcellulose as a thickener were added according to the formulation shown in Table 1, and the mixture was stirred and dissolved in purified water to make a total volume of 100 ml to prepare a lotion.
【0020】[0020]
【表1】 [Table 1]
【0021】試験例1:頭皮塗布試験 被験薬は実施例1〜6ならびに比較例1および2を使用
した。被験動物として、前頭部の禿げた4歳のベニガオ
ザルの雄を使用した。被験動物の頭頂部の脱毛部位に半
径3cmの円を油脂性ペンで描き、円の中心に各被験薬を
5μl/cm2となる量を滴下塗布した。円内の濡れおよび
はじきならびに円外への液剤の垂れについての塗布性に
ついて目視判定した(○:良好、△:やや不良、×:不
良)。Test Example 1: Scalp application test Examples 1 to 6 and Comparative Examples 1 and 2 were used as test drugs. As a test animal, a 4-year-old bald macaque male with a bald frontal part was used. A circle having a radius of 3 cm was drawn on the hair loss site at the top of the test animal with an oily pen, and each test drug was applied dropwise to the center of the circle in an amount of 5 μl / cm 2 . The applicability of wetting and repelling in a circle and dripping of a liquid agent out of the circle was visually judged (:: good, Δ: slightly poor, ×: poor).
【0022】さらに、塗布30分後に円の中心部および
外延部に透明粘着テープを強く張り付けた。1分後にテ
ープをはがし、それぞれの同一面積のテープ粘着面をエ
タノールで抽出した。さらに、それぞれのテープ塗布部
をエタノールをしみこませた脱脂綿でふき取り、先のテ
ープ粘着面からの抽出液と合わせ、HPLC法により含
有するミノキシジル量を定量した。均一性の判定は、中
心部と外延部の含有量の差が5%以下を非常に良好(二
重丸)、10%以下を良好(○)、10%を越える場合
を不良(×)とし、判定した。Further, 30 minutes after the application, a transparent adhesive tape was strongly adhered to the central portion and the outer peripheral portion of the circle. One minute later, the tape was peeled off, and the tape-adhered surface having the same area was extracted with ethanol. Furthermore, each tape-coated portion was wiped with absorbent cotton impregnated with ethanol, combined with the extract from the tape-adhesive surface, and the amount of minoxidil contained was quantified by HPLC. Judgment of uniformity is judged as very good when the difference between the content of the central portion and the extension portion is 5% or less (double circle), good (○) when 10% or less, and poor (x) when it exceeds 10%. Was determined.
【0023】それぞれの結果を表2に示した。Table 2 shows the results.
【0024】[0024]
【表2】 [Table 2]
【0025】試験例2:ベニガオザルによる育毛効果試
験 本発明の薬物の育毛効果の試験は、男性型脱毛症のモデ
ル動物であるベニガオザルを使用し、実施例および比較
例の育毛剤を前頭部の脱毛部位に塗布し、育毛効果を塗
布後の塗布部位の拡大写真から判定した。Test Example 2: Test of hair-growth effect by macaque monkey The test of the hair-growth effect of the drug of the present invention was carried out using a macaque monkey, a model animal of male pattern baldness, using the hair growth preparations of Examples and Comparative Examples in the frontal region. It was applied to the hair loss site, and the hair growth effect was determined from an enlarged photograph of the application site after application.
【0026】被験薬は実施例1〜6ならびに比較例1お
よび2を使用した。試験動物としてベニガオザルの前頭
部の禿げた4歳の雄を使用し、上記育毛剤を週5日、1
日1回、1回1mlを6ヶ月間各動物の前頭部に対し塗布
した。Examples 1 to 6 and Comparative Examples 1 and 2 were used as test drugs. As a test animal, a 4-year-old bald male of the macaque monkey was used.
Once a day, 1 ml was applied to the forehead of each animal for 6 months.
【0027】評価方法は、薬剤塗布部位の前頭部拡大写
真を塗布前と塗布後2ヶ月毎に1回撮影し、頭部発毛部
位(正常部位)と比較し評価した。結果を表3に示し
た。In the evaluation method, enlarged photographs of the frontal region of the drug application site were taken before application and once every two months after application, and compared with the hair growth site (normal site). The results are shown in Table 3.
【0028】[0028]
【表3】 [Table 3]
【0029】[0029]
【発明の効果】本発明により、一定量のミノキシジルを
一定面積の頭皮に均一に塗布することができる、育毛効
果に優れた育毛剤を提供することが可能となった。Industrial Applicability According to the present invention, it has become possible to provide a hair restorer which can apply a fixed amount of minoxidil evenly to a scalp of a fixed area and has an excellent hair restoring effect.
Claims (2)
ジルを配合し、25℃での粘度が1.5〜15mPa・sで
あり、かつ、25℃での表面張力が25〜30dyne/cm
であることを特徴とする外用育毛液剤。1. A composition containing 0.1 to 5% by weight of minoxidil in the whole preparation, having a viscosity at 25 ° C. of 1.5 to 15 mPa · s and a surface tension at 25 ° C. of 25 to 30 dyne / cm
An external hair growth liquid preparation, characterized in that:
0℃以下である極性溶媒および沸点が150℃以上の有
機溶媒を含有する請求項1記載の外用育毛液剤。2. A solvent having a boiling point of 10.
2. The hair growth solution for external use according to claim 1, comprising a polar solvent having a temperature of 0 ° C or lower and an organic solvent having a boiling point of 150 ° C or higher.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9253999A JPH1192378A (en) | 1997-09-19 | 1997-09-19 | Hair tonic liquid for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9253999A JPH1192378A (en) | 1997-09-19 | 1997-09-19 | Hair tonic liquid for external use |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1192378A true JPH1192378A (en) | 1999-04-06 |
Family
ID=17258864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9253999A Pending JPH1192378A (en) | 1997-09-19 | 1997-09-19 | Hair tonic liquid for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH1192378A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030021707A (en) * | 2001-09-07 | 2003-03-15 | 주식회사 엘지생활건강 | O/o/w multiple emulsion containing minoxidil |
JP2004505906A (en) * | 2000-08-09 | 2004-02-26 | フアーマシア アクチエボラグ | New composition of minoxidil |
JP2005350380A (en) * | 2004-06-09 | 2005-12-22 | Meisei Sansho Kk | Hair growing agent-impregnated sheet |
JP2006315973A (en) * | 2005-05-11 | 2006-11-24 | Shiseido Co Ltd | Water-based skin cosmetic |
JP2009269844A (en) * | 2008-05-02 | 2009-11-19 | Fujifilm Corp | Composition for hair |
US20130125915A1 (en) * | 2007-01-30 | 2013-05-23 | Kao Corporation | Hair frizziness reducing agent |
WO2014017573A1 (en) * | 2012-07-27 | 2014-01-30 | 大正製薬株式会社 | Composition for agent for external use |
JP2017524684A (en) * | 2014-06-30 | 2017-08-31 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition containing minoxidil |
JP2019501219A (en) * | 2015-12-28 | 2019-01-17 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition and method |
WO2019088186A1 (en) * | 2017-11-02 | 2019-05-09 | 株式会社 資生堂 | Powdered composition |
JP2021070671A (en) * | 2019-11-01 | 2021-05-06 | 富士化学工業株式会社 | Topical liquid |
-
1997
- 1997-09-19 JP JP9253999A patent/JPH1192378A/en active Pending
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004505906A (en) * | 2000-08-09 | 2004-02-26 | フアーマシア アクチエボラグ | New composition of minoxidil |
US7442369B1 (en) | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
JP2010006829A (en) * | 2000-08-09 | 2010-01-14 | Mcneil Ab | New composition of minoxidil |
KR20030021707A (en) * | 2001-09-07 | 2003-03-15 | 주식회사 엘지생활건강 | O/o/w multiple emulsion containing minoxidil |
JP2005350380A (en) * | 2004-06-09 | 2005-12-22 | Meisei Sansho Kk | Hair growing agent-impregnated sheet |
JP2006315973A (en) * | 2005-05-11 | 2006-11-24 | Shiseido Co Ltd | Water-based skin cosmetic |
US20130125915A1 (en) * | 2007-01-30 | 2013-05-23 | Kao Corporation | Hair frizziness reducing agent |
JP2009269844A (en) * | 2008-05-02 | 2009-11-19 | Fujifilm Corp | Composition for hair |
WO2014017573A1 (en) * | 2012-07-27 | 2014-01-30 | 大正製薬株式会社 | Composition for agent for external use |
CN104487048A (en) * | 2012-07-27 | 2015-04-01 | 大正制药株式会社 | Composition for agent for external use |
JPWO2014017573A1 (en) * | 2012-07-27 | 2016-07-11 | 大正製薬株式会社 | External preparation composition |
JP2017524684A (en) * | 2014-06-30 | 2017-08-31 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition containing minoxidil |
US11000466B2 (en) | 2014-06-30 | 2021-05-11 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
JP2020180164A (en) * | 2014-06-30 | 2020-11-05 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Minoxidil-containing hair growth composition |
JP2020063243A (en) * | 2014-06-30 | 2020-04-23 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition containing minoxidil |
JP2020180165A (en) * | 2014-06-30 | 2020-11-05 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Minoxidil-containing hair growth composition |
JP2019178174A (en) * | 2014-06-30 | 2019-10-17 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Minoxidil-containing hair growth composition |
JP2019505576A (en) * | 2015-12-28 | 2019-02-28 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition and method |
JP2019505577A (en) * | 2015-12-28 | 2019-02-28 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition and method |
US10925824B2 (en) | 2015-12-28 | 2021-02-23 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
JP2019501219A (en) * | 2015-12-28 | 2019-01-17 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth composition and method |
US11039996B2 (en) | 2015-12-28 | 2021-06-22 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
JP2021138764A (en) * | 2015-12-28 | 2021-09-16 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth compositions and methods |
JP2021152065A (en) * | 2015-12-28 | 2021-09-30 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth compositions |
JP2021152066A (en) * | 2015-12-28 | 2021-09-30 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Hair growth compositions |
US11185487B2 (en) | 2015-12-28 | 2021-11-30 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
US11666520B2 (en) | 2015-12-28 | 2023-06-06 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
CN111278412A (en) * | 2017-11-02 | 2020-06-12 | 株式会社资生堂 | Powdered composition |
WO2019088186A1 (en) * | 2017-11-02 | 2019-05-09 | 株式会社 資生堂 | Powdered composition |
JP2021070671A (en) * | 2019-11-01 | 2021-05-06 | 富士化学工業株式会社 | Topical liquid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005314323A (en) | Hair growth formulation | |
EP2498783B1 (en) | Compositions and methods for stimulating hair growth | |
RU2287330C2 (en) | Minoxidyl compositions | |
AU2009278086B2 (en) | Film-forming liquid formulations for drug release to hair and scalp | |
JP4940527B2 (en) | Sustainable hair growth composition | |
WO1998032417A1 (en) | Persistent hair tonic | |
JP4554805B2 (en) | Hair nourishing | |
JPH1192378A (en) | Hair tonic liquid for external use | |
JPH10265343A (en) | Sustained release hair growing agent | |
JP3220761B2 (en) | Hair restoration | |
JPH10218737A (en) | Hair grower | |
KR20080038710A (en) | Epidermal emulsion composition for treating a bald containing minoxidil and tretinoin | |
JP2546813B2 (en) | Hair nourishing cosmetics | |
WO2003030844A1 (en) | Long-acting hair growth stimulant preparations | |
JP3314785B2 (en) | Minoxidil-containing hair restorer | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JP7379094B2 (en) | External liquid | |
JP2001288031A (en) | Additive for hair-growing agent and hair-growing agent composition | |
JPH0640858A (en) | Hair tonic | |
JPH059105A (en) | Hair grower | |
JP4892786B2 (en) | Sustainable hair growth preparation | |
WO2013180229A1 (en) | Composition for hair growth | |
JPH10273424A (en) | Cosmetic for hair | |
JPH10218736A (en) | Hair grower | |
JP2002114645A (en) | Hair tonic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041012 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041026 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050308 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050321 |
|
R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20080408 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090408 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100408 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20110408 |
|
LAPS | Cancellation because of no payment of annual fees |